Survey of more than 1,000 consumers demonstrates concerns over permanent synthetic mesh and highlights a strong desire for shared decision-making and surgeon expertise in innovative, more natural. | June 15, 2023
Company prioritizes education with a variety of in-person and virtual training programsMALVERN, Pa., May 19, 2023 TELA Bio, Inc. , a commercial-stage medical technology company focused on. | May 19, 2023
Study results show a low 2.6% recurrence rate and clinically meaningful improvement in patient quality of lifeMALVERN, Pa., Oct. 26, 2022 TELA Bio, Inc. , a commercial-stage medical technology. | October 26, 2022